ロード中...
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
INTRODUCTION: The aim of the analysis was to characterize the population pharmacokinetics (PKs) and exposure–response (E–R) for efficacy (fasting plasma glucose, glycated hemoglobin) and safety/tolerability [hypoglycemia, genital infections, urinary tract infection (UTI), and volume depletion] of th...
保存先:
| 出版年: | Diabetes Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5014782/ https://ncbi.nlm.nih.gov/pubmed/27312794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0174-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|